James R. Meyers - May 24, 2023 Form 4 Insider Report for Arbutus Biopharma Corp (ABUS)

Role
Director
Signature
/s/ David C. Hastings as attorney-in-fact for James R. Meyers
Stock symbol
ABUS
Transactions as of
May 24, 2023
Transactions value $
$0
Form type
4
Date filed
5/26/2023, 04:06 PM
Previous filing
Jun 17, 2022
Next filing
Jun 5, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABUS Stock Option (Right to Buy) Award $0 +55K $0.00 55K May 24, 2023 Common Shares 55K $2.56 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on May 24, 2023, the date of the grant.
F2 The option is fully vested and exercisable as of the date of the grant.